Exhaled Nitric Oxide is Associated with Allergic Inflammation in Children by Choi, Bong Seok et al.
© 2011 The Korean Academy of Medical Sciences.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) 
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
pISSN 1011-8934
eISSN 1598-6357
Exhaled Nitric Oxide is Associated with Allergic Inflammation  
in Children
Exhaled nitric oxide (eNO) has been proposed as a noninvasive marker of airway 
inflammation in asthma. In asthmatic patients, exhaled NO levels have been shown to 
relate with other markers of eosinophilic recruitment, which are detected in blood, 
sputum, bronchoalveolar lavage fluid and bronchial biopsy samples. The purpose of this 
study was to assess the possible relationship between eNO and allergic inflammation or 
sensitization in childhood asthma and allergic rhinitis. Subjects consisted of 118 asthmatic 
children, 79 patients with allergic rhinitis, and 74 controls. Their age ranged from 6 to 15 
yr old. eNO level, peripheral blood eosinophil count, eosinophil cationic protein (ECP), 
serum total IgE level and specific IgE levels were measured. Methacholine challenge test 
and allergic skin prick test for common allergens were performed in all subjects. Atopic 
group (n = 206, 44.48 ± 30.45 ppb) had higher eNO values than non-atopic group 
(n = 65, 20.54 ± 16.57 ppb, P < 0.001). eNO level was significantly higher in patients 
with asthma (42.84 ± 31.92 ppb) and in those with allergic rhinitis (43.59 ± 29.84 ppb) 
than in healthy controls (27.01 ± 21.34 ppb, P < 0.001) but there was no difference 
between asthma and allergic rhinitis group. eNO also had significant positive correlations 
with Dermatophagoides pteronyssinus IgE level (r = 0.348, P < 0.001), Dermatophagoides 
farinae IgE level (r = 0.376, P < 0.001), and the number of positive allergens in skin prick 
test (r = 0.329, P = 0.001). eNO had significant positive correlations with peripheral blood 
eosinophil count (r = 0.356, P < 0.001), serum total IgE level (r = 0.221, P < 0.001), and 
ECP (r = 0.436, P < 0.001). This study reveals that eNO level is associated with allergic 
inflammation and the degree of allergic sensitization. 
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INTRODUCTION
Allergic diseases, including asthma, continue to increase in prev-
alence in the world (1). A key feature in the pathogenesis of asth-
ma is chronic airway inflammation, characterized by the pres-
ence of inflammatory cells and the release of inflammatory me-
diators in the airways (2). Airway inflammation can be detected 
by several methods such as bronchial biopsy, bronchoalveolar 
lavage or induced sputum (3). However, due to their invasive 
character or low practical applicability, these methods are not 
suitable for use in young children or in large study populations. 
The measurement of nitric oxide concentrations in exhaled air 
has recently been proposed as a non-invasive, simple and well 
tolerated test to assess airway inflammation in asthma, even in 
children (4).
  Exhaled nitric oxide (eNO) is a free-radical gas of endogenous 
origin with multiple biological and pathophysiologic functions, 
detectable in exhaled air of human. eNO in asthmatic patients 
is mainly produced by inducible nitric oxide synthase expressed 
in bronchial epithelial cells and some inflammatory cells (5). 
Allergic sensitization may contribute to eNO in children with 
asthma via late-phase influx of eosinophils (6) and nitric oxide 
formation (7, 8) after aeroallergen exposure. The fact that eNO 
level increase in subjects with mild-to-moderate asthma (9), in-
crease after a late asthmatic reaction to allergens (10), and de-
crease after subjects receive inhaled corticosteroids (9) suggests 
that eNO is closely associated with airway inflammation. In con-
trast, others suggested that atopy and airway inflammation rep-
resented by eNO were separate dimensions in the assessment 
of childhood asthma (11).
  Therefore, the present study aimed to determine whether eNO 
could be related with allergic inflammation and sensitization in 
childhood asthma and allergic rhinitis.
 
MATERIALS AND METHODS
Study subjects
The study included 271 children: 118 asthmatic children, 79 pa-Choi BS, et al.  •  Exhaled NO in Childhood Allergy 
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tients with allergic rhinitis, and 74 controls. Their age ranged 
from 6 to 15 yr old.
  The diagnosis of asthma was made on the basis of American 
Thoracic Society (ATS) criteria (12). The children with asthma 
reported having typical wheezing or episodic shortness of breath, 
and showed either a positive methacholine challenge results 
(PC20 < 16 mg/mL) or an increase by at least 12% in forced expi-
ratory volume in 1 sec (FEV1) after administration of 200 μg of 
salbutamol. Patents were being treated with inhaled β-agonist 
alone on an as-required basis, and had not used any controller 
anti-asthmatic therapy during the 3 months prior to the study. 
They had no respiratory infection in recent 4 weeks. The diag-
nosis of allergic rhinitis was made on the basis of history (watery 
rhinorrhea, blocked nose, sneezing, and nasal itching) and pos-
itive skin prick tests to common allergens or specific IgE concen-
tration assessed as higher than 0.35 IU/mL for at least one aller-
gen. None of the children had ever presented wheezing or re-
ceived asthma medication. Control subjects had no asthma or 
allergic rhinitis symptoms and history. Their PC20 values were 
16 or higher and dFEV1 was lower than 12%. Atopy was defined 
as a positive skin prick tests (wheal diameter > 3 mm) to 16 com-
mon allergens or specific IgE concentration assessed as higher 
than 0.35 IU/mL for at least one allergen or serum total IgE con-
cedntraction  > 150 IU/mL.
  Exclusion criteria for patient recruitment were: 1) Patient who 
was under steroid treatment for the 4 weeks preceding the study 
and 2) Patient who had upper airway infection over the last 4 
weeks.
Exhaled NO measurement
eNO was measured using a fast response chemiluminescence 
analyser (CLD 88 exhalyzer, ECO MEDICS, Duernten, Switzer-
land) according to the ATS recommendations (13). Subjects ex-
haled at a constant flow rate (50 mL/s) from total lung capacity 
to residual volume without breath-holding. Measurement was 
taken before spirometry and methacholine challenge test. The 
mean value of 3 successive reproducible recordings was retained 
for statistical analysis.
Measurement of blood eosinophils, serum total IgE, 
eosinophil cationic protein and specific IgE
Serum was collected and stored at -20°C until assayed. Periph-
eral blood eosinophil counts were done by automated assay (NE-
8000 system, Sysmex, Kobe, Japan). Total serum IgE and eosin-
ophil cationic protein (ECP) were measured (CAP system, Phar-
macia-Upjohn, Uppsala, Sweden) according to the manufac-
turer’s instructions. Specific IgE test was performed on Derma-
tophagoides pteronyssinus (Der p), Dermatophagoides farina 
(Der f), Alternaria, Blatella germinica, cow’s milk and egg white 
(CAP system, Pharmacia-Upjohn, Uppsala, Sweden). A specific 
IgE value greater than 0.35 kIU/L was considered positive. Skin 
prick test (Torii & Co; Tokyo, Japan) measured two types of house 
dust mites, cat and dog epithelium, and mold and pollen anti-
gens. A saline solution was used as a negative control, and a 0.5% 
histamine HCl solution was used as a positive control. The wheal 
diameter was measured after 15 min, and a positive reaction was 
defined as a wheal diameter of 3 mm (14).
Statistical analysis
All statistical tests were performed using the statistical analysis 
program SAS (version 9.1). Comparison of eNO values was per-
formed using logistic regression between different groups. eNO 
values were log transformed before analysis to normalize resid-
uals, and analyses were adjusted for age.
  Pearson’s correlation coefficients were used to assess the re-
lationships among the eNO, biomarkers, and skin prick test re-
sult. The analyses were adjusted for the age.
  A P value of less than 0.05 was considered significant.
Ethics statement
This study was approved by the institutional review board of 
Severance Hospital (Seoul, Korea, 1-2009-0001). Written con-
sent for participation was obtained from parents and verbal as-
sent from children.
RESULTS
Subject characteristics
Study subjects ranged in age from 6 to 15 yr (mean, 8.4). One 
hundred seventy four of them were male, and 97 were female. 
Atopic group consisted of 206 children, and non-atopic group 
65 children. Atopic patients accounted for 83.1% of asthma group, 
100% of allergic rhinitis, and 39.2% of control group. 
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Fig. 1. Comparison of eNO level between atopic asthma, allergic rhinitis (AR), atopic 
control, non-atopic asthma, and non-atopic control. Atopic group (44.48 ± 30.45 ppb) 
had higher eNO values than non-atopic group (20.54 ± 16.57 ppb) (P < 0.001).  Choi BS, et al.  •  Exhaled NO in Childhood Allergy 
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Exhaled NO levels
Atopic group (44.48 ± 30.45 ppb) had higher eNO values than 
non-atopic group (20.54 ± 16.57 ppb, P < 0.001) (Fig. 1). Within 
asthma group, atopic asthma group (48.33 ± 32.28 ppb) had 
higher eNO values than non-atopic asthma group (15.92 ± 5.99 
ppb, P = 0.002).
  eNO level was significantly higher in patients with asthma 
(42.84 ± 31.92 ppb, P < 0.001) and in those with allergic rhinitis 
(43.59 ± 29.84 ppb, P < 0.001) than in healthy controls (27.01 ±  
21.34 ppb). However, there was no difference between asthma 
and allergic rhinitis group.
Correlations between eNO and allergic sensitization
eNO had a significant positive correlation with serum total IgE 
level (r = 0.221, P < 0.001). eNO also had positive correlations 
with Der p IgE level (r = 0.348, P < 0.001) and Der f  IgE level (r =  
0.376, P < 0.001) (Fig. 2). In addition, there was a positive corre-
lation between eNO and the number of positive skin prick test 
(r = 0.329, P = 0.001) (Fig. 3).
Correlation between eNO and eosinophilic inflammation
eNO had positive correlations with peripheral blood eosinophil 
Fig. 2. Correlation between serum total IgE and eNO levels (A), specific IgE of Der p and eNO level (B), and specific IgE of Der f and eNO level (C). eNO had positive correlations 
with serum total IgE level (r = 0.221, P < 0.001), Der p IgE level (r = 0.348, P < 0.001), and Der f IgE level (r = 0.376, P < 0.001). 
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Fig. 3. Correlation between the number of positive skin prick test (SPT) and eNO level. 
The number of positive SPT were positively correlated with eNO level (r = 0.329, P = 
0.001).
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Fig. 4. Correlation between serum total eosinophil count (TEC) and eNO level (A) and serum total ECP and eNO level (B). eNO had positive correlations with TEC (r = 0.356, P < 
0.001) and ECP (r = 0.436, P < 0.001). 
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count (r = 0.356, P < 0.001) and ECP (r = 0.436, P < 0.001) (Fig. 4).
 
DISCUSSION
The major finding of this study is that increased eNO levels have 
been observed in atopic subjects regardless of underlying dis-
eases. eNO levels were higher in asthma group and allergic rhini-
tis group than control group. There was a significant positive cor-
relation between eNO with peripheral blood eosinophil count, 
ECP, total IgE, Der p- and Der f-specific IgE, and the number of 
positive skin prick test. 
  eNO has been widely accepted as a marker of chronic airway 
inflammation (15). Positive correlations have been reported be-
tween eNO and eosinophils in sputum (16), bronchial biopsy 
specimens (17) but have not been observed in some other stud-
ies (18).
  Relationships between eNO and allergic sensitization have 
been previously reported. eNO correlates with total IgE and spe-
cific IgE to house dust mites, and there is a moderate correlation 
with the number of positive skin prick tests (19, 20) and wheal 
size (21). Several studies have reported elevated eNO levels in 
atopic subjects, regardless of the presence of respiratory tract 
symptoms (19, 20). 
  In contrast, some authors failed to find a relationship between 
eNO and allergic sensitization (11, 22). Leung et al. (11) suggest-
ed atopy and airway inflammation to represent separate dimen-
sions of childhood asthma, using factor analysis. However, in 
that study, 59% of patients received inhaled corticosteroids. eNO 
level can decrease after subjects receive inhaled corticosteroids 
(9, 23). Therefore, inhaled corticosteroids treatment could influ-
ence the results. Persson et al. (22) found no difference in a small 
group of subjects in peak eNO concentration between allergic 
and nonallergic asthmatics. However, the number of subjects 
was very small, and 23 patients of 34 asthmatics were receiving 
regular inhaled corticosteroid treatment as well. In our study, 
we showed a positive correlation between eNO and allergic sen-
sitization in 271 subjects, and none of them received corticoste-
roid treatment.
  We used CLD 88 device to measure eNO level which is differ-
ent from that commonly used one approved by FDA. However, 
in our previous study (24), we compared the value of eNO mea-
sured by CLD88 and Niox mino
® (FDA approved), the intraclass 
correlation coefficient was 0.786 (P < 0.001). Therefore our data 
may not be derived from device difference. 
  eNO tends to increase in healthy children up to the age of 17 
yr; thereafter the values are similar to adults (25). The tendency 
may be caused by increased airway size (25). Our findings are 
in agreement with this tendency. Therefore, we adjusted our 
data for age in statistical analysis.
  We showed that eNO levels were correlated with allergic in-
flammation in children. However, we think this finding is not 
limited in pediatric group. There are some similar reports about 
the relationship between eNO and allergic inflammation in adult 
group (26).
  In this study, asthma with allergic rhinitis group did not show 
higher eNO levels than asthma only or allergic rhinitis only group, 
but eNO levels of allergic rhinitis group were as high as those of 
asthma group. So we should be careful when we use eNO as a 
diagnostic or monitoring tool for asthma. Exhaled eNO level el-
evation in allergic rhinitis subjects probably results from allergic 
sensitization itself and a subclinical eosinophilic inflammatory 
process throughout the respiratory tract (27), indicating that rhi-
nitis and asthma represent the manifestation of one syndrome 
with a wide spectrum of severity (28).
  The findings of this study suggests that the allergic nature of 
inflammation of the airways may be mainly responsible for higher 
NO production in the airways. In conclusion, our study shows 
that eNO level correlates with allergic inflammation and the de-
gree of allergic sensitization. 
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We assessed the possible relationship between eNO and allergic inflammation in childhood asthma and allergic rhinitis. Atopic 
group had higher eNO values than non-atopic group. eNO level was significantly higher in patients with asthma and in those with 
allergic rhinitis than in healthy controls. eNO also had significant positive correlations with house dust mite IgE level, and the 
number of positive allergens in skin prick test. eNO had significant positive correlations with peripheral blood eosinophil count, 
serum total IgE level, and ECP. As a whole, eNO level is well associated with allergic inflammation and the degree of allergic 
sensitization.